Volume 59 • 1998 • Supplement 14

Publisher’s Podcast: An Audio Summary of This Issue

Listen to an audio summary of this issue

Subscribe to the Podcast

Introduction/Reboxetine: A New Selective Antidepressant for the Treatment of Depression

J Clin Psychiatry 1998;59(suppl 14):4–7

Antidepressant Efficacy and Tolerability of the Selective Norepinephrine Reuptake Inhibitor Reboxetine: A Review

J Clin Psychiatry 1998;59(suppl 14):4–7

Reboxetine Versus Fluoxetine: An Overview of Efficacy and Tolerability

J Clin Psychiatry 1998;59(suppl 14):8–10

Monoamine Dysfunction and the Pathophysiology and Treatment of Depression

J Clin Psychiatry 1998;59(suppl 14):11–14

Noradrenergic Versus Serotonergic Antidepressants: Predictors of Treatment Response

J Clin Psychiatry 1998;59(suppl 14):15–18

The Measurement of Retardation in Depression

J Clin Psychiatry 1998;59(suppl 14):19–25

Chairman’s Overview/The Place of Reboxetine in Antidepressant Therapy

J Clin Psychiatry 1998;59(suppl 14):26–29